Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
17.96 USD | +0.22% | +0.67% | +60.36% |
Jun. 05 | Harrow, Inc. Announces 52-Week Data from VEVYE ESSENCE-2 Open-Label Extension Study | CI |
Jun. 03 | Lake Street Raises Price Target on Harrow to $25 From $20, Maintains Buy Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+60.36% | 635M | |
+43.64% | 754B | |
+39.49% | 630B | |
-6.58% | 352B | |
+19.72% | 331B | |
+8.78% | 298B | |
+11.70% | 217B | |
-1.76% | 216B | |
+0.03% | 163B | |
+6.13% | 164B |
- Stock Market
- Equities
- HROW Stock
- News Harrow, Inc.
- Transcript : Harrow Health, Inc., Q1 2022 Earnings Call, May 05, 2022